Inflammatix Appoints Purvesh Khatri as Chief Scientific Officer
Inflammatix, Inc., a pioneering molecular diagnostics company, announced today the appointment of Purvesh Khatri, PhD, as Chief Scientific Officer.
- Inflammatix, Inc., a pioneering molecular diagnostics company, announced today the appointment of Purvesh Khatri, PhD, as Chief Scientific Officer.
- As a co-founder of Inflammatix, Dr. Khatri had previously served as a Scientific Advisor to the company while serving as Associate Professor at Stanford Universitys Institute for Immunity, Transplantation, and Infection.
- Dr. Khatri possesses more than 15 years of experience in bioinformatics, computational biology, and translational medicine.
- Dr. Khatri added, I am excited to make a full-time commitment to Inflammatix as it continues its work to address important unmet needs in the diagnosis of acute illness.